EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Innate Immune Response to Viral Vectors in Gene Therapy

Yixuan Wang, Wenwei Shao

Viruses · 24.08.2023 · 15 (9) · 1801

DOI: 10.3390/v15091801 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 24.08.2023. Verfasst von Yixuan Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Academy of Medical Engineering and Translational Medicine, Medical College, Tianjin University, Tianjin 300072, China. Hauptthemen laut MEDLINE: Immunity, Innate, Signal Transduction. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology of the People’s Republic of China, National Key Research and Development Program of China, National Natural Science Foundation of China, the Youth Fund of the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Viral vectors play a pivotal role in the field of gene therapy, with several related drugs having already gained clinical approval from the EMA and FDA. However, numerous viral gene therapy vectors are currently undergoing pre-clinical research or participating in clinical trials. Despite advancements, the innate response remains a significant barrier impeding the clinical development of viral gene therapy. The innate immune response to viral gene therapy vectors and transgenes is still an important reason hindering its clinical development. Extensive studies have demonstrated that different DNA and RNA sensors can detect adenoviruses, adeno-associated viruses, and lentiviruses, thereby activating various innate immune pathways such as Toll-like receptor (TLR), cyclic GMP-AMP synthase–stimulator of interferon genes (cGAS-STING), and retinoic acid-inducible gene I–mitochondrial antiviral signaling protein (RLR-MAVS). This review focuses on elucidating the mechanisms underlying the innate immune response induced by three widely utilized viral vectors: adenovirus, adeno-associated virus, and lentivirus, as well as the strategies employed to circumvent innate immunity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunity, InnateSignal TransductionToll-Like ReceptorsAdenoviridaeGenetic Therapy

Stichwörter der Autor:innen

adeno-associated virusadenovirusinnate immunelentivirus

Substanzen

Toll-Like Receptors

Autor:innen und Institutionen

  • Academy of Medical Engineering and Translational Medicine, Medical College, Tianjin University, Tianjin 300072, China.

Förderung

  • Ministry of Science and Technology of the People’s Republic of China, National Key Research and Development Program of China
  • National Natural Science Foundation of China, the Youth Fund of the National Natural Science Foundation of China

Zitieren

APA

Wang, Y., & Shao, W. (2023). Innate Immune Response to Viral Vectors in Gene Therapy. Viruses, 15(9), 1801. https://doi.org/10.3390/v15091801

Vancouver

Wang Y, Shao W. Innate Immune Response to Viral Vectors in Gene Therapy. Viruses. 2023;15(9):1801. doi:10.3390/v15091801

BibTeX
@article{Wang2023,
  author = {Wang, Yixuan and Shao, Wenwei},
  title = {Innate Immune Response to Viral Vectors in Gene Therapy},
  journal = {Viruses},
  year = {2023},
  volume = {15},
  number = {9},
  pages = {1801},
  doi = {10.3390/v15091801}
}
Kostenlos starten →